DENDREON CORP's ticker is DNDNQ and the CUSIP is 24823Q107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $30,000 | -52.4% | 21,150 | -22.5% | 0.02% | -48.4% |
| Q2 2014 | $63,000 | -23.2% | 27,300 | -0.9% | 0.03% | -22.5% |
| Q1 2014 | $82,000 | -10.9% | 27,550 | -10.1% | 0.04% | -13.0% |
| Q4 2013 | $92,000 | +1.1% | 30,650 | -0.8% | 0.05% | -8.0% |
| Q3 2013 | $91,000 | -35.5% | 30,900 | -9.9% | 0.05% | -40.5% |
| Q2 2013 | $141,000 | – | 34,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 1,824,183 | $2,627,000 | 0.05% |
| ARISTEIA CAPITAL, L.L.C. | 1,000,000 | $1,440,000 | 0.05% |
| Quotient Investors, LLC | 156,100 | $225,000 | 0.05% |
| Spark Investment Management LLC | 208,900 | $300,000 | 0.04% |
| WOLVERINE ASSET MANAGEMENT LLC | 26,236 | $2,019,000 | 0.04% |
| TANG CAPITAL MANAGEMENT LLC | 55,548 | $80,000 | 0.04% |
| Point72 Asset Management, L.P. | 3,000,000 | $4,320,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 154,756 | $223,000 | 0.02% |
| Adamant Biomedical Investments AG | 50,000 | $72,000 | 0.02% |
| A.R.T. Advisors, LLC | 261,266 | $376,000 | 0.02% |